Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA | 8 | 2024 | 426 | 1.900 |
Why?
|
| RNA, Untranslated | 14 | 2014 | 105 | 1.900 |
Why?
|
| X Chromosome Inactivation | 10 | 2023 | 60 | 1.250 |
Why?
|
| RNA, Nuclear | 2 | 2024 | 13 | 1.040 |
Why?
|
| RNA, Long Noncoding | 18 | 2023 | 171 | 1.030 |
Why?
|
| Chromatin | 7 | 2023 | 641 | 0.900 |
Why?
|
| Interphase | 2 | 2016 | 68 | 0.870 |
Why?
|
| Alu Elements | 1 | 2024 | 9 | 0.860 |
Why?
|
| Chromosomes, Human, X | 8 | 2011 | 35 | 0.850 |
Why?
|
| Chromosomes | 2 | 2016 | 139 | 0.710 |
Why?
|
| Cell Nucleus | 8 | 2024 | 630 | 0.600 |
Why?
|
| Euchromatin | 3 | 2021 | 16 | 0.580 |
Why?
|
| Genome, Human | 3 | 2024 | 237 | 0.530 |
Why?
|
| DNA Demethylation | 1 | 2017 | 3 | 0.520 |
Why?
|
| Polycomb-Group Proteins | 1 | 2017 | 21 | 0.510 |
Why?
|
| DNA, Satellite | 1 | 2017 | 24 | 0.510 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2017 | 18 | 0.500 |
Why?
|
| Chromosomes, Mammalian | 2 | 2014 | 33 | 0.490 |
Why?
|
| Cell Line | 9 | 2013 | 2024 | 0.450 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2014 | 85 | 0.430 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 407 | 0.380 |
Why?
|
| X Chromosome | 4 | 2023 | 52 | 0.370 |
Why?
|
| Dosage Compensation, Genetic | 5 | 2013 | 23 | 0.330 |
Why?
|
| Embryonic Stem Cells | 2 | 2009 | 154 | 0.330 |
Why?
|
| Gene Silencing | 9 | 2023 | 433 | 0.320 |
Why?
|
| Cell Differentiation | 2 | 2008 | 1386 | 0.310 |
Why?
|
| Heterochromatin | 5 | 2024 | 98 | 0.300 |
Why?
|
| Genomic Imprinting | 2 | 2010 | 49 | 0.280 |
Why?
|
| Chromosome Painting | 2 | 2003 | 6 | 0.250 |
Why?
|
| Base Sequence | 3 | 2017 | 1332 | 0.250 |
Why?
|
| Neoplasms | 1 | 2017 | 1368 | 0.240 |
Why?
|
| RNA Precursors | 1 | 2006 | 78 | 0.230 |
Why?
|
| Genome | 2 | 2020 | 285 | 0.230 |
Why?
|
| BRCA1 Protein | 3 | 2017 | 68 | 0.230 |
Why?
|
| Ribonucleoproteins | 1 | 2006 | 116 | 0.230 |
Why?
|
| Nuclear Proteins | 3 | 2021 | 790 | 0.220 |
Why?
|
| Mice | 10 | 2024 | 11119 | 0.210 |
Why?
|
| Stem Cells | 1 | 2005 | 276 | 0.200 |
Why?
|
| Translocation, Genetic | 1 | 2002 | 74 | 0.190 |
Why?
|
| Humans | 24 | 2024 | 65140 | 0.180 |
Why?
|
| Animals | 12 | 2024 | 21345 | 0.180 |
Why?
|
| In Situ Hybridization, Fluorescence | 5 | 2013 | 161 | 0.180 |
Why?
|
| Chromosomes, Human | 1 | 2002 | 52 | 0.180 |
Why?
|
| Transcription Factors | 4 | 2013 | 1556 | 0.170 |
Why?
|
| Transcription, Genetic | 5 | 2014 | 907 | 0.150 |
Why?
|
| Gene Expression Regulation | 3 | 2013 | 1630 | 0.140 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2017 | 31 | 0.130 |
Why?
|
| Protein Aggregates | 1 | 2017 | 24 | 0.130 |
Why?
|
| Genetic Loci | 1 | 2017 | 116 | 0.120 |
Why?
|
| RNA, Messenger | 2 | 2017 | 1574 | 0.120 |
Why?
|
| Brain | 1 | 2024 | 1605 | 0.110 |
Why?
|
| Fibroblasts | 3 | 2008 | 422 | 0.110 |
Why?
|
| Sex Chromatin | 3 | 2013 | 10 | 0.110 |
Why?
|
| Hybrid Cells | 1 | 2014 | 19 | 0.100 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 1565 | 0.100 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2014 | 18 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 583 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2013 | 30 | 0.100 |
Why?
|
| Down Syndrome | 1 | 2013 | 47 | 0.090 |
Why?
|
| RNA Interference | 3 | 2013 | 643 | 0.090 |
Why?
|
| Female | 11 | 2010 | 34018 | 0.090 |
Why?
|
| Models, Biological | 1 | 2017 | 1192 | 0.090 |
Why?
|
| Transgenes | 2 | 2009 | 204 | 0.080 |
Why?
|
| Aurora Kinase B | 1 | 2009 | 4 | 0.080 |
Why?
|
| Aurora Kinases | 1 | 2009 | 12 | 0.080 |
Why?
|
| Protein Phosphatase 1 | 1 | 2009 | 19 | 0.080 |
Why?
|
| Mediator Complex | 1 | 2009 | 13 | 0.080 |
Why?
|
| Indoles | 1 | 2009 | 112 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2009 | 391 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2009 | 136 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2010 | 351 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2008 | 53 | 0.070 |
Why?
|
| DNA | 1 | 2013 | 858 | 0.070 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2009 | 182 | 0.070 |
Why?
|
| Macrophages | 1 | 2013 | 1038 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 367 | 0.070 |
Why?
|
| Cell Cycle | 1 | 2009 | 398 | 0.060 |
Why?
|
| Cellular Senescence | 1 | 2008 | 121 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2013 | 827 | 0.060 |
Why?
|
| Mothers | 1 | 2010 | 280 | 0.060 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2006 | 14 | 0.060 |
Why?
|
| Inflammation | 1 | 2013 | 1192 | 0.060 |
Why?
|
| Genes, X-Linked | 1 | 2006 | 22 | 0.060 |
Why?
|
| Dinucleotide Repeats | 1 | 2006 | 7 | 0.060 |
Why?
|
| Spliceosomes | 1 | 2006 | 42 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 318 | 0.060 |
Why?
|
| Teratogens | 1 | 2005 | 4 | 0.060 |
Why?
|
| Embryo Research | 1 | 2005 | 4 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2007 | 166 | 0.060 |
Why?
|
| Male | 8 | 2013 | 31047 | 0.060 |
Why?
|
| Azacitidine | 1 | 2005 | 15 | 0.060 |
Why?
|
| Models, Molecular | 1 | 2009 | 1162 | 0.060 |
Why?
|
| RNA Splicing | 1 | 2006 | 170 | 0.060 |
Why?
|
| Aneuploidy | 1 | 2005 | 42 | 0.060 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2004 | 8 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 426 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 676 | 0.050 |
Why?
|
| Cell Nucleolus | 1 | 2004 | 71 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2004 | 113 | 0.050 |
Why?
|
| Carcinoma, Embryonal | 1 | 2003 | 5 | 0.050 |
Why?
|
| Dactinomycin | 1 | 2003 | 11 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2006 | 350 | 0.050 |
Why?
|
| Klinefelter Syndrome | 1 | 2002 | 4 | 0.050 |
Why?
|
| Gene Expression | 2 | 2003 | 852 | 0.050 |
Why?
|
| Turner Syndrome | 1 | 2002 | 9 | 0.050 |
Why?
|
| Karyotyping | 1 | 2002 | 48 | 0.050 |
Why?
|
| Acetylation | 1 | 2002 | 121 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 794 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2003 | 236 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2008 | 713 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2007 | 1222 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 401 | 0.040 |
Why?
|
| Karyotype | 1 | 2020 | 18 | 0.040 |
Why?
|
| DNA Methylation | 2 | 2013 | 302 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2008 | 3153 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2003 | 801 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2013 | 1038 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 447 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 663 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2013 | 8 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2013 | 61 | 0.020 |
Why?
|
| Models, Immunological | 1 | 2013 | 85 | 0.020 |
Why?
|
| DNA Probes | 1 | 2013 | 33 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2013 | 94 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 2013 | 41 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 2013 | 52 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2013 | 115 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2013 | 64 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 197 | 0.020 |
Why?
|
| Cytosol | 1 | 2013 | 182 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2013 | 160 | 0.020 |
Why?
|
| Transfection | 2 | 2004 | 700 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2013 | 434 | 0.020 |
Why?
|
| Animals, Congenic | 1 | 2010 | 4 | 0.020 |
Why?
|
| Embryo Loss | 1 | 2010 | 14 | 0.020 |
Why?
|
| Fathers | 1 | 2010 | 22 | 0.020 |
Why?
|
| Blastocyst | 1 | 2010 | 74 | 0.020 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2009 | 17 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 952 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2010 | 226 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2009 | 72 | 0.020 |
Why?
|
| Ribonuclease III | 1 | 2008 | 87 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2008 | 158 | 0.020 |
Why?
|
| Genes, BRCA1 | 1 | 2007 | 17 | 0.020 |
Why?
|
| Fibrosarcoma | 1 | 2007 | 14 | 0.020 |
Why?
|
| Doxycycline | 1 | 2007 | 47 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2007 | 165 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2008 | 312 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 1290 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2007 | 146 | 0.020 |
Why?
|
| DNA Damage | 1 | 2008 | 297 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2007 | 266 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2006 | 213 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 414 | 0.010 |
Why?
|
| Adult | 1 | 2002 | 17358 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 896 | 0.010 |
Why?
|
| Diploidy | 1 | 2004 | 11 | 0.010 |
Why?
|
| Leupeptins | 1 | 2004 | 16 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2006 | 296 | 0.010 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 2004 | 14 | 0.010 |
Why?
|
| Proteasome Inhibitors | 1 | 2004 | 32 | 0.010 |
Why?
|
| Homozygote | 1 | 2004 | 122 | 0.010 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2004 | 40 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2004 | 41 | 0.010 |
Why?
|
| Heterozygote | 1 | 2004 | 173 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 2188 | 0.010 |
Why?
|
| Histones | 1 | 2007 | 494 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 210 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2004 | 541 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 285 | 0.010 |
Why?
|
| Cattle | 1 | 2003 | 320 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 1994 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2004 | 2157 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 1225 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2002 | 918 | 0.010 |
Why?
|